Form 4: Sanofi Insider Reports Stock Transaction
Insider Transaction (Form 4)
Sanofi, a 10% owner of Sanofi, reported multiple transactions in common stock on August 10, 2026.
Summary
- Conversion of derivative: acquired 494,800 Common Stock on August 10, 2026; holds 494,800 after (Indirect).
- Conversion of derivative: acquired 177,978 Common Stock on August 10, 2026; holds 672,788 after (Indirect).
- Conversion of derivative: disposed of 494,800 Series B Preferred Stock on August 10, 2026 (Indirect).
- Conversion of derivative: disposed of 177,978 Convertible Promissory Note on August 10, 2026 (Indirect).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Sanofi — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-10 | Conversion of derivative | Common Stock | 494,800 | — | — | 494,800 |
| 2026-08-10 | Conversion of derivative | Common Stock | 177,978 | — | — | 672,788 |
| 2026-08-10 | Conversion of derivative | Series B Preferred Stock | 494,800 | — | — | 0 |
| 2026-08-10 | Conversion of derivative | Convertible Promissory Note | 177,978 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-10 | Conversion of derivative (494,800 shares) |
| 2026-08-10 | Conversion of derivative (177,978 shares) |
| 2026-08-10 | Conversion of derivative (494,800 shares) |
| 2026-08-10 | Conversion of derivative (177,978 shares) |
Keywords
insider transaction, Form 4, LTGO, Latigo Biotherapeutics, Inc., neutral, Sanofi
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.